ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,818Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 20

$980K Total Retail Price of All Prescriptions

Rank: 1 out of 20

565 Patients Receiving at Least One Drug in Part D
13%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

8% of this provider’s 1,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
RISPERIDONE 922 219 1 1
MIRTAZAPINE 571 184 2 4
TRAZODONE HCL 564 44 3 3
SERTRALINE HCL 492 84 4 8
CITALOPRAM HBR 489 57 5 2
BENZTROPINE MESYLATE 459 66 R 6 6
QUETIAPINE FUMARATE 417 0 7 5
ABILIFY 416 35 8 9
LITHIUM CARBONATE 374 0 9 12
FLUOXETINE HCL 372 92 10 15
BUSPIRONE HCL 360 26 11 18
DIVALPROEX SODIUM ER 336 44 12 14
ZOLPIDEM TARTRATE 314 0 13 24
VENLAFAXINE HCL ER 298 22 14 7
BUPROPION HCL SR 292 20 15 17
LAMOTRIGINE 290 37 16 11
GABAPENTIN 280 51 17 21
PAROXETINE HCL 264 14 18 25
BUPROPION HCL 221 18 10 19 29
SEROQUEL XR 214 0 20 23
ESCITALOPRAM OXALATE 150 38 21 16
CHLORPROMAZINE HCL 149 13 22 27
AMITRIPTYLINE HCL 145 0 R 23 32
OLANZAPINE 144 0 24 10
TOPIRAMATE 143 0 25 33
SEROQUEL 139 0 26 20
CLOMIPRAMINE HCL 136 24 R 27 34
CYMBALTA 134 0 28 19
HYDROXYZINE PAMOATE 131 14 R 29 31
CLOZAPINE 112 11 30 13
HALOPERIDOL 111 25 31 37
METHYLPHENIDATE HCL 110 0 32 39
THIORIDAZINE HCL 107 12 R 33 40
ZIPRASIDONE HCL 94 0 34 28
FLUPHENAZINE HCL 94 14 34 42
OXCARBAZEPINE 90 0 36 43
PROPRANOLOL HCL 85 0 37 44
PRAZOSIN HCL 74 15 38 48
FLUVOXAMINE MALEATE 70 16 39 49
BUPROPION XL 67 0 40 26
DEXTROAMPHETAMINE SULFATE 65 0 S2 41 51
DOXEPIN HCL 65 0 41 51
AMPHETAMINE SALT COMBO 62 0 S2 43 53
THIOTHIXENE 60 0 44 37
LEXAPRO 59 0 45 56
CLONIDINE HCL 53 0 46 59
LEVOTHYROXINE SODIUM 52 0 47 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.